US2023127134A1PendingUtilityA1

Methods for cancer treatment

Assignee: DROPLET BIOSCIENCES INCPriority: Sep 20, 2021Filed: Dec 22, 2022Published: Apr 27, 2023
Est. expirySep 20, 2041(~15.2 yrs left)· nominal 20-yr term from priority
A61M 2027/004A61M 27/002A61M 1/70A61M 2202/0405A61M 1/88A61M 5/1414A61M 5/1723A61M 2039/0273A61M 2039/0276A61B 5/418A61B 5/14546A61B 5/4839A61B 5/6852A61B 5/6866
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to novel surgical drains and associated methods and systems. Specifically, the present invention includes a surgical drain with at least two ports. A first port drains lymphatic fluid from a subject for collection and analysis. The second port functions to introduce a therapeutic into the subject.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for treating cancer, the method comprising
 obtaining surgical drain fluid via an implanted drain;   evaluating one or more biomarkers in the drain fluid;   administering a treatment via the implanted drain based on characteristics of the biomarkers; and   obtaining subsequent drain fluid samples to evaluate efficacy of the treatment.   
     
     
         2 . The method of  claim 1 , wherein the biomarkers are selected from cfDNA, ctDNA, a protein, pathogenic DNA or RNA, leukocyte DNA, and epigenetic factors. 
     
     
         3 . The method of  claim 1 , wherein the treatment is a systemic chemotherapeutic. 
     
     
         4 . The method of  claim 1 , wherein the treatment is a local chemotherapeutic. 
     
     
         5 . The method of  claim 1 , wherein the treatment is an immunotherapy. 
     
     
         6 . The method of  claim 1 , wherein the subsequent drain fluid sample is obtained within one hour of the administering step, one day of the administering step, or one week after the administering step. 
     
     
         7 . The method of  claim 1 , wherein the biomarker is an antibody or antibody fragment.

Join the waitlist — get patent alerts

Track US2023127134A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.